XT
COLL icon

XTX Topco’s Collegium Pharmaceutical COLL Stock Holding History

XTX Topco’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
44,187
+6,654
+18% +$227K 0.02% 1334
2026
Q1 		$1.24M Buy
37,533
+27,798
+286% +$1.18M 0.02% 1231
2025
Q4 		$451K Sell
9,735
-5,884
-38% -$246K 0.01% 1700
2025
Q3 		$547K Buy
+15,619
New +$543K 0.03% 1003
2025
Q2 		– Sell
-21,317
Closed -$636K – 2476
2025
Q1 		$636K Buy
21,317
+13,092
+159% +$400K 0.03% 848
2024
Q4 		$236K Buy
+8,225
New +$272K 0.02% 1420

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

XTX Topco's COLL Position: Q2 2026 in Review

XTX Topco increased its Collegium Pharmaceutical (COLL) stake by 18% in Q2 2026, buying an estimated $227K and bringing the position to 44,187 shares worth $1.6M. The position accounts for 0.02% of the portfolio, ranked #1334.

XTX Topco first reported a position in COLL in Q4 2024 and has held it in 6 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • XTX Topco held 44,187 shares of Collegium Pharmaceutical worth $1.6M as of Q2 2026.
  • XTX Topco bought 6,654 Collegium Pharmaceutical shares in Q2 2026, an estimated $227K.
  • Collegium Pharmaceutical made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1334 holding.
  • XTX Topco first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.